Clinical Trials Directory

Trials / Completed

CompletedNCT01150734

Neuromodulation in Depressed and Schizophrenic Patients - Changing MEP (Muscle Evoked Potentials) by tDCS (Transcranial Direct Current Stimulation)

Transcranial Direct Current Stimulation (tDCS)-Boosted Changes in Muscle Evoked Potentials (MEP) in Depressed and Schizophrenic Patients Reveal Deficits in Neuromodulation

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Ludwig-Maximilians - University of Munich · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Muscle evoked potentials (MEP) are supposed to different in schizophrenic and depressed patients, compared to a sample of healthy volunteers. Transcranial Magnetic Stimulation (TMS)-evoked MEP are measured in all three groups at baseline and after tDCS (2 mA, 20 minutes). MEP amplitudes are supposed to normalize quickly in healthy volunteers, to stay diminished in depressed patients and to stay elevated in schizophrenic patients. These differences should disappear after regular pharmacological treatment. Outcome measures will be done in week 2 and week 4.

Conditions

Timeline

Start date
2009-10-01
Primary completion
2010-12-01
Completion
2011-01-01
First posted
2010-06-25
Last updated
2011-04-22

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01150734. Inclusion in this directory is not an endorsement.